MLPH Dividend: Molecular Pharmacology (USA) Ltd Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

MLPH Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	06/30/2014	06/30/2013	06/30/2012	06/30/2011	06/30/2010
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	0	0	0	0	0	0
Research & Development	--	--	--	--	--	--
Operating Expenses	0	0	0	0	0	0
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	0	0	0	0	0	0
Income Tax Expense	0	0	0	0	0	0
Net Income	0	0	0	0	0	0
Net Income Growth	--	--	--	--	--	--
Shares Outstanding (Diluted)	111.55	111.55	111.55	111.55	111.55	111.55
Shares Change (YoY)	0%	0%	0%	0%	0%	0%
EPS (Diluted)	0	0	0	0	0	0
EPS Growth	125%	-42%	19%	45%	0%	22%
Free Cash Flow	0	0	0	0	0	0
Free Cash Flow Per Share	0	0	0	0	0	0
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	0	0	0	0	0	0
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	0	0	0	0	0	0
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%